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Abstract 29 
 30 
Dengue viruses (DENV) are characterized by extensive genetic diversity, which can be 31 
organized in multiple, genetically distinct lineages that arise and die out on a regular basis 32 
in endemic regions. A fundamental question for understanding DENV evolution is the 33 
relative extent to which stochastic processes (genetic drift) and natural selection acting on 34 
fitness differences among lineages contribute to lineage diversity and turnover. Here, we 35 
used a set of recently collected and archived low-passage DENV-1 isolates from Thailand 36 
to examine the role of mosquito vector-virus interactions in DENV evolution. By 37 
comparing the ability of 23 viruses isolated on different dates between 1985 and 2009 to 38 
be transmitted by a present-day Aedes aegypti population from Thailand, we found that a 39 
major clade replacement event in the mid-1990s was associated with virus isolates 40 
exhibiting increased titers in the vector’s hemocoel, which is predicted to result in a 41 
higher probability of transmission. This finding is consistent with the hypothesis that 42 
selection for enhanced transmission by mosquitoes is a possible mechanism underlying 43 
major DENV clade replacement events. There was significant variation in transmission 44 
potential among isolates within each clade, indicating that in addition to vector-driven 45 
selection other evolutionary forces act to maintain viral genetic diversity. We conclude 46 
that occasional adaptive processes involving the mosquito vector can drive major DENV 47 
lineage replacement events. 48 
49 
 4
INTRODUCTION 50 
 51 
Worldwide, dengue viruses (DENV) are the most important mosquito-borne viral 52 
pathogens of humans. The four antigenically distinct DENV serotypes (DENV-1 to -4) 53 
cause a broad spectrum of clinical manifestations. An estimated 50 million people 54 
experience dengue illness each year, approximately 500,000 of which are associated with 55 
severe, life-threatening disease (18). In addition, a significant portion of infections can be 56 
inapparent and, thus, go undetected by surveillance programs (15). Despite the large 57 
disease burden imposed by dengue on the human population, there is currently no 58 
commercially available DENV vaccine or antiviral therapy (46). In endemic regions 59 
where multiple serotypes co-circulate, DENV epidemiological dynamics are 60 
characterized by complex oscillations in incidence and serotype prevalence (6, 32, 43). A 61 
variety of ecological (10, 24) and immunological factors (1, 36) are thought to govern 62 
these complex spatio-temporal dynamics. There is also compelling evidence for the 63 
influence of virological factors in disease incidence and severity (reviewed in ref. 37). 64 
DENV are single-stranded, positive-sense RNA viruses of the genus Flavivirus (family 65 
Flaviviridae) with extensive genetic diversity (21). Each serotype can be divided into 66 
large, genetically diverse phylogenetic clusters, which, in turn, consist of multiple, 67 
distinct lineages (22). Hereafter, we use the terms clade and lineage interchangeably. In 68 
the last two decades, in-depth phylogenetic analyses have significantly improved 69 
understanding of DENV epidemiological and evolutionary dynamics (reviewed in refs. 70 
35, 45). 71 
 72 
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One of the most striking features of DENV evolutionary dynamics is that viral lineages 73 
within serotypes arise and die out on a regular basis (22). This lineage turnover is 74 
detected in phylogenetic analyses in two different, non-mutually exclusive forms: (i) 75 
continuous, “ladder-like” temporal structure within clades and (ii) more dramatic, major 76 
clade replacement events. Within a clade, the majority of sub-lineages present at a 77 
specific time-point are not detected at later time-points, resulting in a ladder-like tree 78 
topology (8, 13, 26). Occasionally, an entire clade that persisted for a number of years at 79 
a given location goes extinct as an entirely new clade takes over. Such major clade 80 
replacement events have been recurrently documented at regional scales, for example 81 
DENV-3 in Sri Lanka in the late 1980s (30), DENV-4 in Puerto Rico during the 1980s-82 
1990s (8), DENV-1 in Thailand in the mid-1990s (48), DENV-3 in Thailand in the early 83 
1990s (47), DENV-1 in Myanmar in the late 1990s (31), DENV-2 in Vietnam in the early 84 
2000s (43), and DENV-1 in Cambodia in the early 2000s (14). Major clade replacement 85 
events have also been reported at larger scales. For example, DENV-2 lineages from 86 
Southeast Asia displaced a native DENV-2 lineage in the Americas during the early 87 
1990s (38). Although successive clades may be temporally non-overlapping (9), in most 88 
cases there is a transition period of co-circulation (14, 30, 31, 43, 47, 48). 89 
 90 
Understanding the causes of DENV lineage birth-and-death has important implications 91 
for dengue epidemiology and control because it is often associated with changes in 92 
disease incidence and severity (16, 17, 30, 31, 38, 40). Elucidating the mechanisms 93 
underlying lineage turnover helps to retrospectively understand spatio-temporal patterns 94 
of dengue incidence and to make predictions about the risk of future epidemics (43).  It 95 
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also has implications for vaccine design because DENV lineages may differ in their 96 
antigenic properties (39, 44). 97 
 98 
Despite their epidemiological significance, the evolutionary forces underlying major 99 
clade replacement events are especially unclear. In particular, the extent to which clade 100 
replacement events result from the random sampling of viral variants (genetic drift) due 101 
to the stochastic nature of DENV transmission and/or from differences in fitness among 102 
variants (i.e., adaptive evolution) is an unresolved question. Analyses of DENV gene 103 
sequence data have shown that clade replacement events are sometimes associated with 104 
signals of positive natural selection, such as an increase in the rate of nonsynonymous 105 
substitutions (7), but not always (26, 47). Some phylogenetic studies have concluded that 106 
major clade replacements were primarily due to stochastic events (31, 47), whereas others 107 
found potentially causal differences in viral fitness between lineages, such as higher 108 
viremia level in the human host (43) or enhanced infectivity to mosquito vectors (3, 5, 109 
19). 110 
 111 
Here, we addressed the question whether DENV evolution could be driven by adaptation 112 
to mosquito vectors using a set of 23 low-passage DENV-1 isolates from Thailand 113 
collected during the period 1985-2009. The 23 isolates were recovered from human 114 
serum as part of the routine dengue diagnostic and surveillance services performed at the 115 
Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok. We 116 
compared the ability of the 23 isolates to be transmitted by Aedes aegypti, the principal 117 
DENV vector species, in experimental in vivo vector competence assays. We 118 
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hypothesized that if viruses are positively selected for enhanced mosquito transmission, a 119 
relative increase in transmission potential should be observed for viruses collected over 120 
advancing years. All experiments were carried out during 2009-2010 using the first 121 
laboratory-reared generation of mosquitoes derived from a wild Ae. aegypti population 122 
collected in Kamphaeng Phet, Thailand. Although we cannot be sure that these 123 
mosquitoes exactly reproduce the vector-virus interactions that occurred at different dates 124 
in the past, they are the most relevant vector population of reference available to test our 125 
hypothesis. We estimated virus transmissibility with two distinct, complementary vector 126 
competence indices: the proportion of Ae. aegypti females that developed a DENV 127 
infection that disseminated from their midgut into their hemocoel, a requirement for virus  128 
transmission by a mosquito, and the infectious titer of disseminated virus (27). 129 
130 
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MATERIALS AND METHODS 131 
 132 
Mosquitoes. Wild Ae. aegypti immatures (larvae and pupae) were collected from a 133 
variety of artificial containers in several households in Nhong Pling, Kon Tee, Nakorn 134 
Choom, Na Bo Kham, and Thep Na Korn sub-districts, Muang district, Kamphaeng Phet 135 
Province, Thailand during July 2009 (experiment 1) and March 2010 (experiment 2). In a 136 
preliminary experiment, immatures were collected from containers in villages of 137 
Ladkrabang district, Bangkok, and Muang district, Kamphaeng Phet Province, in January 138 
2009. F0 adults were allowed to emerge in the laboratory, mate randomly, and feed on 139 
defibrinated sheep blood (National Laboratory Animal Center, Mahidol University, 140 
Bangkok, Thailand) through a membrane feeding system. F1 eggs, which were collected 141 
and stored on dry pieces of paper towel and maintained under high humidity, were 142 
hatched synchronously by placing them under low pressure for 30 min. Larvae were 143 
reared in 24 x 34 x 9 cm plastic trays filled with 2.0 l of dechlorinated tap water at a 144 
density of approximately 200 first instars per tray and fed a standard diet of 145 
approximately 1.0 g of fish food pellets (C.P. Hi Pro®, Perfect Companion Group Co. 146 
Ltd, Bangkok, Thailand) per tray. After emergence, F1 adults were housed in plastic 30 x 147 
30 x 30 cm cages (Megaview Science Education Service Co. Ltd, Taichung, Taiwan) 148 
with permanent access to 10% sucrose. They were maintained under standard insectary 149 
conditions at 28±1°C, 80% humidity, and with a 12:12 hour light:dark cycle. 150 
 151 
Virus isolates. Viruses were originally isolated and archived as seed stocks from serum 152 
samples collected during routine surveillance for diagnostic public health testing at 153 
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AFRIMS from clinically ill dengue patients attending Kamphaeng Phet Provincial 154 
Hospital in Kamphaeng Phet (experiment 1) and Queen Sirikit National Institute of Child 155 
Health in Bangkok (experiment 2). Virus isolation and identification was performed as 156 
previously described (25). Each isolate underwent 3-4 passages in cell culture (Table 1), 157 
which, according to standard procedures in our AFRIMS laboratory, is the minimum 158 
required to obtain a viral titer sufficiently high to infect mosquitoes orally using an 159 
artificial blood meal.  160 
 161 
Oral challenge. Two sets of two-day-old confluent cultures of Aedes albopictus cells 162 
(C6/36, ATCC #CRL-1660TM) in 25 cm2 flasks (approximately 107 cells/flask) were 163 
inoculated with 1.0 ml of stock virus per flask and incubated at 35°C under 5% CO2. A 164 
similar titer can be reached by growing virus in C6/36 cells at 35°C for 4-6 days instead 165 
of the usual 7-10 days at 28°C. In experiment 1, supernatant was harvested at 5 and 6 166 
days post-inoculation to prepare the infectious blood meal of experimental blocks 1 and 167 
2, respectively. In experiment 2, supernatant was harvested at 4 days post-inoculation to 168 
prepare the infectious blood meal of both experimental blocks. The protocol difference 169 
between experiments 1 and 2 was due to logistical constraints. The artificial blood meal 170 
consisted of 1:1 mix of defibrinated sheep blood (National Laboratory Animal Center, 171 
Mahidol University, Bangkok, Thailand) and virus suspension. Three- to seven-day-old 172 
Ae. aegypti F1 females deprived of sucrose and water for 24 hours were offered an 173 
infectious blood meal for 30 min through pieces of desalted porcine intestine stretched 174 
over water-jacketed glass feeders maintained at 37°C. Samples of the blood meal were 175 
saved for subsequent titration by plaque assay. After blood feeding, mosquitoes were 176 
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briefly sedated with CO2 from dry ice and fully engorged females were transferred to 177 
clean paper cups. Unfed or partially fed females were discarded. Engorged females were 178 
maintained under standard insectary conditions and provided cotton soaked with 10% 179 
sucrose ad libitum. 180 
 181 
Vector competence. The ability of DENV isolates to be transmitted by Ae. aegypti was 182 
assessed at 7 and 14 days post blood meal (pbm) with two vector competence 183 
phenotypes: (i) the proportion of mosquitoes that developed a disseminated infection and 184 
(ii) the infectious titer of disseminated virus. These two complementary indices of vector 185 
competence represent two successive, non-overlapping aspects of the infection process in 186 
mosquitoes that lead to their ability to transmit virus, namely that virus disseminates 187 
beyond the midgut and the magnitude of infectious titer in the hemocoel. As such, we 188 
analyzed them separately. The two periods of extrinsic incubation (7 and 14 days pbm) 189 
were chosen to represent early and late phases of dissemination kinetics (28). 190 
Relationship between the infectious titer of disseminated virus and the potential for 191 
transmission in vitro was established in a preliminary experiment (see below). Upon 192 
harvest, the head of each female was cut off and placed individually in 1.0 ml of 193 
mosquito diluent (MD), consisting of RPMI 1640 medium with 10% heat-inactivated 194 
FBS with 100 units/ml penicillin and 100 µg/ml streptomycin. Bodies were kept 195 
separately in 1.0 ml of MD. Samples were stored at –70°C before processing. Body and 196 
head samples were quickly thawed in a water bath at 35±2°C and homogenized in a 197 
mixer mill (Qiagen) at 24 cycles/sec for 2 min. Infected bodies were screened by 198 
serotype-specific RT-PCR (experiment 1) or plaque assay (experiment 2). In experiment 199 
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1, total RNA was extracted from 140 µl of body homogenates using QIAamp viral RNA 200 
mini kit (Qiagen) according to the manufacturer’s instructions. RT-PCR was performed 201 
with 5 µl of extracted RNA following a standard protocol (29) with the following 202 
modifications: (i) 1X PCR buffer II supplied with Amplitaq DNA Polymerase (Applied 203 
Biosystems) was used instead of the original buffer (50 mM KCl, 10 mM Tris pH 8.5 and 204 
0.01 mM gelatin) in both the first round RT-PCR and the second round PCR (nested 205 
PCR); (ii) the first round RT-PCR reaction contained Avian myeloblastosis virus reverse 206 
transcriptase (Promega) instead of rav-2 recombinant reverse transcriptase; (iii) the 1:50 207 
dilution of the first round RT-PCR product was used as the template in the nested PCR; 208 
(iv) the nested PCR reaction contained 12.5 pmol of each primer instead of 50 pmol; and 209 
(v) the number of the nested PCR cycles was increased from 20 cycles to 25 cycles (29). 210 
Plaque assay was performed in rhesus monkey kidney cells (LLC-MK2, ATCC #CCL-211 
7TM) as described previously (42). Briefly, the homogenized samples were passed 212 
individually through a 0.22 µm syringe filter unit and 1:2, 1:10 and 1:100 dilutions were 213 
prepared in MD. The samples were placed in an ice bath and 100 µl/well were inoculated 214 
into a monolayer of LLC-MK2 cells in 24-well plates. The virus was adsorbed for 1 hour 215 
at room temperature (20-28ºC) on a rocker platform. The inoculum was removed and 0.5 216 
ml/well of a first overlay of medium was added. The cells were incubated for 5 days at 217 
35±1ºC in a 5±0.5% CO2 incubator. The cells were stained with a second overlay of 218 
medium containing 4% neutral red (Sigma). Plaques were counted and plaque forming 219 
units (PFU)/ml were calculated. Head samples of infected bodies were titrated by plaque 220 
assay in LLC-MK2 cells. Mosquitoes whose bodies were negative by RT-PCR 221 
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(experiment 1) or plaque assay (experiment 2) were considered uninfected and their 222 
heads were not processed further. 223 
 224 
In vitro transmission. A preliminary experiment was carried out to define the 225 
relationship between the titer of disseminated virus and the potential for in vitro virus 226 
transmission. This experiment involved two F1 populations of Ae. aegypti sampled during 227 
January-February 2009 in Bangkok and Kamphaeng Phet, respectively. Both populations 228 
were experimentally exposed to two 2009 DENV-1 isolates from Bangkok (ID# 229 
00076/09 and 00088/09) and two 2009 DENV-1 isolates from Kamphaeng Phet (ID# 230 
30015/09 and 30025/09). The relationship between the titer of disseminated virus and in 231 
vitro transmission success was evaluated both at 8 and 14 days pbm. Mosquitoes were 232 
anesthetized with triethylamine (Sigma-Aldrich), and their legs were removed 233 
individually and placed into 1.0 ml of MD. Saliva samples were collected using a forced 234 
salivation technique (2). Briefly, mosquito mouthparts were inserted for 15 min into a 235 
glass microcapillary tube filled with approximately 10 μl of FBS. After 15 min, the 236 
contents of the microcapillary tube were placed into 0.3 ml of MD and snap-frozen in dry 237 
ice. The remainder of the mosquito bodies were placed individually into 1.0 ml of MD, 238 
and all samples were stored at –70°C before processing. Body and leg samples were 239 
quickly thawed in a water bath at 35±2°C and homogenized in a mixer mill. Infected 240 
bodies were screened by serotype-specific RT-PCR as described above. The titer of 241 
disseminated virus in the legs of mosquitoes whose body was positive by RT-PCR was 242 
determined by plaque assay in LLC-MK2 cells as described above. Mosquitoes whose 243 
bodies were negative by RT-PCR were considered uninfected and their legs were not 244 
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processed further. The presence of virus in the saliva samples from mosquitoes with a 245 
disseminated infection was tested by plaque assay in LLC-MK2 cells. 246 
 247 
Sequencing and phylogenetic analysis. Viral RNA extracted by QIAamp viral RNA 248 
mini kit was converted to cDNA using Transcriptor High Fidelity kit (Roche) and random 249 
hexamer oligonucleotides according to the manufacturer’s instructions. Sequencing of E 250 
genes and complete genomes was performed following previously described methods 251 
(48). The DNA fragments of the E gene and the overlapping DNA fragments covering the 252 
entire DENV-1 genome were amplified using Amplitaq DNA Polymerase (Applied 253 
Biosystems) and purified using QIAquick PCR purification kit and QIAquick gel 254 
extraction kit (Qiagen). Purified DNA fragments were used as templates in cycle 255 
sequencing reactions using the DYEnamic ET dye terminator sequencing kit (GE 256 
Healthcare) according to the manufacturer’s instructions. The sequencing primers were 257 
described previously (48). The sequencing products were purified by standard ethanol 258 
precipitation before sequencing in a MegaBACE 500 automated DNA sequencer (GE 259 
Healthcare). The overlapping sequences obtained from forward and reverse primers were 260 
combined for analysis and edited by using the Sequencher software (Gene Code 261 
Corporation). Phylogenetic trees were constructed with PAUP* version 4.0 (41) using a 262 
maximum likelihood (ML) method. ML trees included the new sequences generated in 263 
this study and 17 “background” DENV-1 sequences from GenBank. The best model of 264 
nucleotide substitution was chosen with jModelTest (33) based on the lowest akaike 265 
information criterion (AIC) value (34). The TIM2+Γ and GTR+Γ models of nucleotide 266 
substitution were applied to construct the trees for E gene and complete genome 267 
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sequences, respectively. Reliability of particular phylogenetic groupings was calculated 268 
using bootstrap resampling analysis with 1,000 replicate neighbor-joining (NJ) trees 269 
under the ML substitution models. All sequences have been submitted to GenBank and 270 
assigned accession numbers JN638322-JN638344. 271 
 272 
Data analysis. All statistical analyses of vector competence data included the 273 
confounding effects of the experiment and the experimental block. The study was run in 274 
two separate experiments that involved two different sets of DENV isolates and used a 275 
population of Ae. aegypti that was sampled at two different times. In both experiments, 276 
the same batch of mosquitoes was exposed twice to the same set of DENV isolates on 277 
two successive days (i.e., two experimental blocks). In the two blocks, viruses came from 278 
the same passage in cell culture but were harvested separately (see above). The effect of 279 
the block was thus nested within each experiment and accounted for the difference in titer 280 
between the two harvests, the effect of the one-day difference in mosquito age, and the 281 
effect of any uncontrolled differences between the two days. The isolate effect was nested 282 
within each experiment and clade because each isolate belonged to only one phylogenetic 283 
clade and each experiment involved a different set of isolates. Blood meal titers were log-284 
transformed (to ensure normal distribution of the residuals) and compared using a 285 
multifactorial analysis of variance (MANOVA) accounting for the effects of clade, 286 
experiment, block and their interactions. The proportion of mosquitoes with a 287 
disseminated infection was analyzed with a nominal logistic regression that included the 288 
effects of blood meal titer, experiment, experimental block, clade, isolate and their 289 
interactions. The titer of disseminated virus was log-transformed (to ensure normal 290 
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distribution of the residuals) and analyzed with a MANOVA that included the effects of 291 
blood meal titer, experiment, experimental block, clade, isolate and their interactions. 292 
Differences were considered statistically significant at P<0.05. Analyses were performed 293 
with the software JMP version 5.1.2. 294 
295 
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RESULTS 296 
 297 
Estimation of transmission potential. Transmission potential was defined as the 298 
presence of infectious virus in the mosquito’s saliva. In a preliminary experiment, a total 299 
of 322 individual Ae. aegypti females that developed a disseminated infection following 300 
oral challenge were tested for virus titer in their legs and virus presence in their saliva 301 
collected in vitro. The data included two F1 Ae. aegypti populations (sampled in Bangkok 302 
and Kamphaeng Phet, respectively), four DENV-1 isolates (two from Bangkok and two 303 
from Kamphaeng Phet), and two extrinsic incubation periods (8 and 14 days pbm). Leg 304 
titers ranged from 1 x 101 to 2.3 x 104 plaque forming units per ml (PFU/ml) and 305 
infectious virus was detected in 7.5% of saliva samples. The probability of detecting 306 
infectious virus in saliva was positively correlated with the infectious titer of 307 
disseminated virus (Fig. 1). Logistic regression showed that the leg titer was a highly 308 
significant predictor of virus detection in saliva (df=1; L-R χ2=15.48; P<0.0001). In 309 
particular, no virus was detected in any of the saliva samples from mosquitoes with a leg 310 
titer < 1 x 103 PFU/ml. For the rest of the study, the infectious titer of disseminated virus 311 
was used as an estimate of transmission potential. Because the number of mosquito legs 312 
may vary among individuals (they can lose them over time), the head titer was used 313 
instead of the leg titer. Previous data showed that the leg titer and the head titer are 314 
strongly correlated in individual Ae. aegypti (27). 315 
 316 
Phylogenetic relationships between DENV isolates. All but two of the 23 DENV-1 317 
isolates were passaged four times in cell culture (Table 1) prior to their use in 318 
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experimental mosquito infections; two were passaged three times. The study was run in 319 
two separate experiments involving two different sets of virus isolates (11 in the first 320 
experiment and 12 in the second) and Ae. aegypti mosquitoes sampled at two different 321 
times. Phylogenetic analysis based on the complete DENV E gene sequence indicated 322 
that the virus isolates could be divided into two major phylogenetic clades within the 323 
genotype I of DENV-1 (Fig. 2A). The first clade included 8 isolates sampled between 324 
1985 and 1995; the second clade included 15 isolates sampled between 1992 and 2009. 325 
Hereafter, the first and second clades are termed “early clade” and “new clade”, 326 
respectively, in reference to the chronological order of their detection. Complete genome 327 
sequences obtained for a selection of 9 isolates sampled between 1986 and 1997 (6 from 328 
the early clade and 3 from the new clade) confirmed the phylogenetic relationships 329 
inferred using the E gene sequence (Fig. 2B). 330 
 331 
Variation in transmission potential among DENV isolates. Vector competence assays 332 
included a total of 738 individual Ae. aegypti females. Transmission potential was 333 
characterized based on 7-44 (mean 32) individuals per isolate. Infectious titer of artificial 334 
blood meals used in vector competence assays varied among isolates (Fig. 3), ranging 335 
from 3.5 x 104 PFU/ml to 3.0 x 106 PFU/ml. Blood meal titers were significantly higher 336 
in the second experiment (SS=3.251; df=1; F=19.63; P<0.0001), but they were not 337 
significantly different between blocks within experiments (SS=0.574; df=2; F=1.734; 338 
P=0.191). The higher blood meal titers in experiment 2 may have resulted from the 339 
different harvest date post-inoculation in cell culture (day 4) compared to experiment 1 340 
(day 5-6). Importantly, blood meal titers did not differ between clades (SS=0.439; df=1; 341 
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F=2.649; P=0.112) (Fig. 2). In the early clade, blood meal titers ranged from 4.5 x 104 342 
PFU/ml to 3.0 x 106 PFU/ml (mean 7.0 x 105 PFU/ml). In the new clade, blood meal 343 
titers ranged from 3.5 x 104 PFU/ml and 2.4 x 106 PFU/ml (mean 8.2 x 105 PFU/ml). 344 
 345 
Overall, about two thirds of mosquitoes were infected (65.6% at 7 days pbm and 69.6% 346 
at 14 days pbm). Nearly all infected females developed disseminated infections within the 347 
first two weeks pbm (52.9% at 7 days pbm and 94.6% at 14 days pbm). The percentage 348 
of females with a disseminated infection (including uninfected individuals) varied 349 
significantly among isolates at both 7 and 14 days pbm (Table 2). It ranged from 0 to 350 
81% at 7 days pbm (mean 32%) and from 20 to 100% (mean 64%) at 14 days pbm. The 351 
percentage of females with a disseminated infection was not significantly influenced by 352 
the blood meal titer, but it was significantly higher in the first than in the second 353 
experiment at 14 days pbm (Table 2). The higher level of dissemination in the second 354 
experiment may have been due to either the different geographical origin of viruses 355 
(Bangkok vs. Kamphaeng Phet) or any uncontrolled, environmental difference between 356 
the two experiments. There was no significant difference between the early and new 357 
clade in the mean percentage of females with a disseminated infection at either 7 or 14 358 
days pbm (Table 2). Dissemination tended to increase as a function of the year of virus 359 
isolation in the early clade whereas it tended to decrease as a function of the year of virus 360 
isolation in the new clade, both at 7 days pbm (Fig. 4A) and 14 days pbm (Fig. 4B). 361 
These trends may have been a consequence of variation in blood meal titers, which 362 
showed similar patterns (Fig. 3). 363 
 364 
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Among females with a disseminated infection, head titers ranged from 1.0 x 101 to 2.3 x 365 
104 PFU/ml at 7 days pbm (N=128, mean 5.4 x 102 PFU/ml, median 3.0 x 101 PFU/ml), 366 
and from 1.0 x 101 to 2.9 x 104 PFU/ml at 14 days pbm (N=243, mean 3.4 x 103 PFU/ml, 367 
median 1.5 x 103 PFU/ml). The titer of disseminated virus was not significantly 368 
influenced by the blood meal titer; it differed significantly among isolates at 14 days pbm 369 
(Table 3). The mean head titer of the new clade was significantly higher than that of the 370 
early clade at 14 days pbm (Table 3; Fig. 5). At 7 days pbm, the new clade had a higher 371 
mean head titer than the early clade, but the difference was marginally insignificant 372 
(Table 3; Fig. 5). The statistical power at 7 days pbm, however, was reduced compared to 373 
14 days pbm because the number of mosquitoes with a disseminated infection was half as 374 
large. At 7 days pbm the head titer tended to increase slightly as a function of the year of 375 
virus isolation in the new clade, whereas it did not vary temporally in the early clade (Fig. 376 
4C). At 14 days pbm, the head titer tended to increase as a function of the year of virus 377 
isolation in the early clade, whereas it did not vary temporally in the new clade (Fig. 4D). 378 
 379 
 380 
381 
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DISCUSSION 382 
 383 
By comparing the ability of 23 DENV-1 isolates from Thailand spanning a 24-year 384 
period to infect and be transmitted by Ae. aegypti, we found that a major clade 385 
replacement event in the mid-1990s was associated with a higher transmission potential 386 
of the isolates belonging to the new clade. Higher transmissibility was mainly due to a 387 
higher infectious titer of virus in the vector’s hemocoel, which is predicted to result in a 388 
higher probability of transmission. This finding supports the hypothesis that major clade 389 
replacement events can be driven by natural selection and emphasizes the potentially 390 
important role of vector-virus interactions in DENV evolution. 391 
 392 
The major clade replacement event revealed by the phylogenetic analysis of the 23 393 
isolates of our study was described previously (48). In their study, Zhang et al. (48) 394 
observed that the DENV-1 clade replacement was associated with a decline in DENV-1 395 
prevalence and a concomitant rise of DENV-4 in Thailand. They speculated that clade 396 
replacement events might result from differential susceptibility to cross-reactive immune 397 
responses in the human host. Here, we provide a non-mutually exclusive, alternative 398 
explanation. Our data suggest that this clade replacement event may have been driven, at 399 
least in part, by adaptation to mosquito vectors. Even though it occurred in a context of 400 
declining DENV-1 incidence, the new clade may have outcompeted the early clade 401 
through enhanced mosquito transmission. Isolates in the new clade had a higher 402 
dissemination titer, which is expected to result in higher viral fitness because the 403 
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probability of transmission by a mosquito is positively correlated with the quantity of 404 
virus that circulates in the insect’s hemocoel. 405 
 406 
Our estimate of DENV transmission potential relied on an experiment demonstrating a 407 
positive correlation between the titer of disseminated virus and the probability of virus 408 
detection in the mosquito’s saliva (Fig. 1). Virus presence in the saliva was determined 409 
using an established in vitro method (2) that likely underestimates transmission 410 
probability because it may fail to detect small, but transmissible amounts of virus. Indeed, 411 
infectious virus was only detected in the saliva of 7.5% of females with a disseminated 412 
infection. Our analysis showed, however, that the probability to detect infectious virus in 413 
saliva samples was positively correlated with the infectious titer of disseminated virus, 414 
across two different Ae. aegypti populations and four different DENV-1 isolates. In 415 
particular, there was a lower threshold titer below which none of the mosquitoes with a 416 
disseminated infection had a positive saliva sample. Although the actual threshold may be 417 
lower than we estimate due to the relatively low sensitivity of the method, our data 418 
established that the titer of disseminated virus is a strong predictor of transmission 419 
probability in this system. 420 
 421 
It is worth noting that we did not consider other entomological parameters underlying 422 
DENV transmission such as vector survival or biting rate, which could potentially vary 423 
among viruses. Future studies will determine whether variation of these traits contribute 424 
to fitness differences among viruses. Another limitation of the study was that adaptation 425 
to cell culture could have occurred during the 3-4 passages of virus amplification prior to 426 
 22
their use in experimental infections of mosquitoes. The selection regime, however, was 427 
the same for all isolates, thus comparisons among vector competence phenotypes 428 
remained meaningful. The mechanisms underlying the phenotypic differences we 429 
observed between the two clades remain unknown. Authors of a recent study suggested 430 
that variation in vector competence among DENV-2 lineages does not depend on 431 
mosquito midgut binding affinity, but rather on replication ability (12). 432 
 433 
Investigators who preceded us and studied DENV-2 and DENV-3 indicated that vector-434 
driven selection could play an important role in DENV evolution. By comparing the 435 
ability of three DENV-3 isolates of a native lineage and three DENV-3 isolates of an 436 
invasive lineage to be transmitted by Ae. aegypti, Hanley et al. (19) showed that a clade 437 
replacement event in Sri Lanka during the 1980s was associated with enhanced mosquito 438 
transmission potential for the invasive lineage. Enhanced transmissibility was associated 439 
with a higher body titer and an increased proportion of Ae. aegypti females with a 440 
disseminated infection (19). At a larger geographic scale, Rico-Hesse and others 441 
suggested in a series of studies that displacement of a native DENV-2 lineage in the 442 
Americas by Southeast Asian DENV-2 lineages during the early 1990s was driven in part 443 
by adaptation to mosquitoes (3-5, 11). In both the DENV-3 and DENV-2 cases, invasive 444 
lineages were associated with more severe disease in humans, which highlights the 445 
critical need to more fully explore the connection between DENV evolutionary biology 446 
and dengue epidemiology.  447 
 448 
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Our study helps to understand the respective contributions of stochastic and adaptive 449 
processes in DENV evolution. Frequent introductions of new lineages (gene flow) are 450 
known to maintain substantial DENV genetic diversity even at a very local scale (23). In 451 
contrast, elimination of deleterious mutations (purifying selection) strongly limits in situ 452 
evolution of lineages (23). Purifying selection is likely the dominant evolutionary force in 453 
DENV evolution (20), and nucleotide fixation events are due primarily to genetic drift 454 
(13, 20, 26). Although stochastic processes are undoubtedly important in DENV 455 
evolution, the present study indicates that more dramatic major clade replacement events 456 
may have an adaptive basis (43). That extinction of the early DENV-1 clade was 457 
concomitant with rise of the new clade, with an overlapping period in the early 1990s 458 
(48), was suggestive of a fitness difference between the two clades. The relatively modest 459 
average fitness difference between the two clades (a 0.5-log difference in head titer) may 460 
explain why they co-circulated for at least four years before the early clade went extinct. 461 
It is worth noting that we also observed significant variation in vector competence indices 462 
within each clade (Fig. 4), indicating that other evolutionary forces than vector-driven 463 
selection promote DENV genetic diversity. In particular, the temporal pattern within each 464 
clade did not provide a clear indication that adaptation to mosquitoes occurs continuously 465 
through time (Fig. 4). We speculate that the temporal trends observed within clades 466 
resulted from uncontrolled variation in experimental blood meal titers (Fig. 3), but this 467 
merits further investigation. 468 
 469 
Although other selective forces may be important drivers of DENV evolution, especially 470 
those occurring in the human host that we did not examine, we provide evidence for the 471 
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possible role of adaptation to mosquito vectors in a major DENV-1 clade replacement 472 
event in Thailand in the early 1990s. Our results reinforce the idea that vector-virus 473 
interactions can play a critical role in DENV epidemiological and evolutionary dynamics, 474 
and suggest that the role of vector-mediated selection be investigated in other instances of 475 
clade replacement. 476 
477 
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Table 1. DENV-1 isolates used in experimental mosquito infections. For each isolate, 665 
the year of virus isolation, location of origin, number of passages in cell culture, and 666 
phylogenetic group (clade) are indicated. KPPH: Kamphaeng Phet Provincial Hospital; 667 
QSNICH: Queen Sirikit National Institute for Child Health (Bangkok); TS: 668 
Toxorhynchites splendens mosquitoes; C6/36: Aedes albopictus cells. 669 
 670 
Experiment Isolation year Isolate ID Source Passage History Clade 
1 1986 KD86-035 KPPH TS-1, C6/36-3 Early 
1990 KD90-157  KPPH TS-1, C6/36-2 Early 
1992 KD92-080  KPPH TS-1, C6/36-2 Early 
1995 30399/95 KPPH C6/36-4 New 
1997 30231/97 KPPH C6/36-4 New 
2000 30529/00 KPPH C6/36-4 New 
2003 30247/03 KPPH C6/36-4 New 
2005 30230/05 KPPH C6/36-4 New 
2006 30118/06 KPPH C6/36-4 New 
2009 30015/09 KPPH C6/36-4 New 
2009 30025/09 KPPH C6/36-4 New 
2 1985 D85-372 QSNICH TS-1, C6/36-3 Early 
1986 D86-412 QSNICH TS-1, C6/36-3 Early 
1987 D87-116 QSNICH TS-1, C6/36-3 Early 
1990 D90-1197 QSNICH TS-1, C6/36-3 Early 
1992 03881/92 QSNICH TS-1, C6/36-3 New 
 36
1995 00407/95 QSNICH TS-1, C6/36-3 Early 
1997 00616/97 QSNICH TS-1, C6/36-3 New 
2000 04805/00 QSNICH TS-1, C6/36-3 New 
2003 01417/03 QSNICH TS-1, C6/36-3 New 
2005 00442/05 QSNICH TS-1, C6/36-3 New 
2007 02128/07 QSNICH C6/36-4 New 
2009 00132/09 QSNICH C6/36-4 New 
 671 
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Table 2. Logistic regression analysis of dissemination prevalence 7 and 14 days post-673 
blood meal among mosquitoes experimentally exposed to different DENV-1 isolates. 674 
df: degrees of freedom; L-R: likelihood ratio. *P<0.05; **P<0.01. 675 
 676 
 Dissemination 7 
days pbm 
Dissemination 14 
days pbm 
Source df L-R χ2 P-value L-R χ2 P-value 
Blood meal titer 1 1.451 0.228 0.749 0.387 
Experiment 1 1.058 0.304 11.45 0.001** 
Clade 1 0.877 0.349 3.619 0.057 
Experiment*Clade 1 0.443 0.506 0.461 0.497 
Block [within Experiment] 2 1.604 0.448 11.34 0.003** 
Block*Clade [within Experiment] 2 0.080 0.961 4.236 0.120 
Isolate [within Experiment, 
Clade] 
19 34.82 0.015* 46.21 0.001** 
 677 
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Table 3. Analysis of variance of head titers at 7 and 14 days post-blood meal among 679 
mosquitoes experimentally exposed to different DENV-1 isolates. Titers were log-680 
transformed to satisfy statistical assumptions. The analysis is performed on individual 681 
females with a disseminated infection (i.e., excluding those that did not develop a 682 
disseminated infection). df: degrees of freedom; SS: sum of squares. *P<0.05; **P<0.01. 683 
 684 
 Head titer 7 days pbm Head titer 14 days pbm 
Source df SS F 
ratio 
P-
value 
df SS F 
ratio 
P-value
Blood meal titer 1 2.005 4.086 0.046* 1 0.027 0.048 0.828 
Experiment 1 2.651 5.403 0.022* 1 0.353 0.633 0.427 
Clade 1 1.898 3.869 0.052 1 5.494 9.838 0.002**
Experiment*Clade 1 0.235 0.479 0.491 1 0.007 0.013 0.908 
Block [within 
Experiment] 
2 0.787 0.802 0.451 2 0.483 0.433 0.649 
Block*Clade [within 
Experiment] 
2 3.215 3.276 0.042* 2 3.153 2.823 0.062 
Isolate [within 
Experiment, Clade] 
19 15.60 1.673 0.054 19 26.76 2.522 0.001**
Error 100 49.06   215 120.1   
  685 
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FIGURE LEGENDS 687 
 688 
Figure 1. Mosquito transmission potential strongly correlates with infectious titer of 689 
disseminated DENV-1. The percentage of female Ae. aegypti tested positive for 690 
infectious virus in saliva samples collected in vitro is shown as a function of infectious 691 
virus titers in their legs at either 8 or 14 days post-blood meal. Bars represent individuals 692 
with a leg liter > the lower value of the corresponding interval on the x-axis. Data shown 693 
is pooled from vector competence assays involving two mosquito populations exposed to 694 
four different DENV-1 isolates (see Materials and Methods for details). Dotted, vertical 695 
lines indicate the 95% confidence intervals of percentages. Sample sizes are indicated 696 
above the bars. 697 
 698 
Figure 2. Phylogenetic relationships among DENV-1 isolates. Maximum likelihood 699 
trees based on E gene (A) or complete genome (B) sequences. Sequences from GenBank 700 
are in black font and sequences generated in this study are in color. Blue and red fonts 701 
indicate isolates used in experiment 1 and 2, respectively. All horizontal branch lengths 702 
are drawn to scale, with bootstrap support values shown next to relevant nodes. 703 
 704 
Figure 3. Variation of artificial DENV-1 blood meal titers in vector competence 705 
assays. Infectious titers of the artificial blood meals measured by plaque assay are shown 706 
for each isolate as a function of their date of isolation and phylogenetic group. Each 707 
isolate was tested twice in two experimental blocks (for details see Materials and 708 
Methods). Lines represents linear y=f(x) regressions to give a graphical indication of 709 
 40
temporal trends. Lower lines correspond to experimental block 1; upper lines correspond 710 
to experimental block 2. 711 
 712 
Figure 4. Variation in vector competence indices among DENV-1 isolates. In the 713 
upper panels, the percentage of females with a disseminated infection is indicated at 7 714 
days post-blood meal (pbm) (A) and 14 days pbm (B) as a function of the year of virus 715 
isolation and phylogenetic group (clade). In the lower panels, mean infectious titer in 716 
heads of females with a disseminated infection is indicated for each isolate at 7 days pbm 717 
(C) and 14 days pbm (D) as a function of virus isolation year and phylogenetic group. 718 
Each isolate is represented by the mean of two experimental blocks (for details see 719 
Materials and Methods). Lines represents linear y=f(x) regressions to give a graphical 720 
indication of temporal trends. 721 
 722 
Figure 5. DENV-1 isolates in the new clade disseminate at higher titers in orally 723 
challenged Ae. aegypti. Bars show the mean head titer of isolates belonging to the early 724 
and new clades at 7 and 14 days post-blood meal. Error bars indicate the standard errors 725 
of the means. Statistical significance of difference between clades is given by P-values 726 
derived from a complete multifactorial analysis of variance accounting for the effects of 727 
infectious dose (blood meal titer), experiment, block, clade and isolates; the analysis only 728 
includes mosquitoes with a disseminated infection. 729 





